Abstract: A method for establishing multiple radio connections by a user equipment (UE) is described. The method includes receiving a first physical downlink control channel (PDCCH) that includes a first cyclic redundancy check (CRC) scrambled by a first cell radio network temporary identifier (C-RNTI) in a primary radio connection. The method also includes decoding the first PDCCH. The method also includes receiving a second PDCCH that includes a second CRC scrambled by a second C-RNTI in a secondary radio connection. The method also includes decoding the second PDCCH.

Abstract: The laminate of an embodiment is a laminate including an antireflection film and a protection film bonded onto the antireflection film, wherein the surface of the antireflection film includes a plurality of protrusions; the protection film includes a supporting film and an adhesive layer; the adhesive layer includes an adhesive agent, a copolymer, and a carboxyl group-containing monomer; the weight average molecular weight of the copolymer is 1000000 or more and 2000000 or less; the copolymer includes the (meth)acrylic acid alkyl ester with the alkyl group having 4 or less carbon atoms in the largest weight proportion among the monomer components; the acid number of the copolymer is 16 mg KOH/g or more and 120 mg KOH/g or less; and the mixing amount of the epoxy cross-linking agent in relation to 100 parts by weight of the copolymer is 1.5 parts by weight or more.

Abstract: The present invention provides a liquid crystal display device which can achieve cost reduction, excellent productivity, and a high contrast ratio within a wide viewing angle range. The liquid crystal display device of the present invention includes, in the order set forth, a first polarizer, a first ?/4 plate, a liquid crystal cell, a second ?/4 plate, a third Type-I birefringent layer, a Type-IV birefringent layer, and a second polarizer. An in-plane slow axis of the first ?/4 plate forms an angle of about 45° with an absorption axis of the first polarizer. An in-plane slow axis of the second ?/4 plate is substantially perpendicular to the in-plane slow axis of the first ?/4 plate. An absorption axis of the second polarizer is substantially perpendicular to the absorption axis of the first polarizer. An in-plane slow axis of the third Type-I birefringent layer is substantially parallel with the absorption axis of the second polarizer.

Abstract: The present invention is directed to secondary alcohol substituted triazole compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Abstract: There is provided a photoelectric conversion element which can prevent the contact resistance between a non-crystalline semiconductor layer containing impurities and an electrode formed on the non-crystalline semiconductor layer from increasing, and can improve the element characteristics. A photoelectric conversion element (10) includes a semiconductor substrate (12), a first semiconductor layer (20n), a second semiconductor layer (20p), a first electrode (22n), and a second electrode (22p). The first semiconductor layer (20n) has a first conductive type. The second semiconductor layer (20p) has a second conductive type opposite to the first conductive type. The first electrode (22n) is formed on the first semiconductor layer (20n). The second electrode (22p) is formed on the second semiconductor layer (20p). At least one electrode of the first electrode (22n) and the second electrode (22p) includes a plurality of metal crystal grains.

Abstract: This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

Abstract: The present invention relates to Polycyclic Heterocycle Derivatives, such as compound 1: (1) compositions comprising the Polycyclic Heterocycle Derivatives, and methods of using the Polycyclic Heterocycle Derivatives for treating or preventing HCV infection in a patient.

Abstract: An in-vivo monitoring camera system that includes: a camera support tube (13) of which one end part is introduced into a body; a camera unit (11) which joins with the camera support tube in the body; a joining portion which joins the camera unit and the support tube to each other; a camera side cable (12) which is connected to the camera unit, and is drawn out toward the outside of the body through the camera support tube; a control system which is on the outside of the body, is connected to the camera side cable, and includes at least a display apparatus; and a cooling system (77) which cools the camera support tube to which heat of the imaging unit is transferred.

Abstract: In the present invention, a device is provided with a main surface member, a piezoelectric body plate, a first support part, and a housing. The main surface member is used as a vibration plate. The piezoelectric body plate vibrates according to an electric signal. The first support part supports the piezoelectric body plate. The housing has a second support part that supports the main surface member and extends in a prescribed direction that intersects the main surface member. The first support part is secured to the second support so that the second support part vibrates in the prescribed direction according to the vibration of the piezoelectric body plate. The vibration of the piezoelectric body plate is transmitted to the main surface member via the first support part and the second support part, and due to this the main surface member vibrates to generate a sound.

Abstract: In its many embodiments, the present invention provides certain S-imino-S-oxo iminothiazine compounds, including compounds Formula (I): or a tautomers and/or stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomeros and said stereoisomers, wherein RN, R1A, R1B, R2, R3, R4, ring A, RA, m, L1-, and RL are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and may be useful for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including for the possible treatment of Alzheimer's disease, are also disclosed.

Abstract: There are provided a terminal device, a base station device, and an integrated circuit that enable a base station device and a terminal device to determine parameters related to uplink signals or uplink reference signals and to perform efficient communication.

Abstract: A circuit-on-wire (CoW) is provided that is made from a flexible metal wire with an outer surface, and a plurality of discrete electrical control devices formed in series along the metal wire outer surface. Each control device may have an electrical contact accessible through the metal wire. In one aspect, the control device may have a via through the metal wire from the top surface to the bottom surface with a second electrical contact accessible through the via. In addition, the control devices may have a top surface with an accessible third electrical contact. For example, the control device may be a first thin-film transistor (TFT), with a gate electrode accessible through the metal wire, wherein the second electrical contact is a first source/drain (S/D) electrode, and wherein the third electrical contact is a second S/D electrode. Using the above-described CoW, a woven active matrix array can be fabricated.

Abstract: Substituted cyclopropyl compounds of the formula I and the pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the g-protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included. Another aspect of the invention that is of interest relates to compounds of formula 1a.

Abstract: A source AMP output circuit (10) is provided with a switching circuit (17) for carrying out the following operation. That is, in a case where a polarity is reversed, the switching circuit (17) disconnects a data signal line (S(M)) from output terminals of a positive amplifier circuit (15) and a negative polarity amplifier circuit (16) each included in the source AMP output circuit (10), and then connects the data signal line S(M) to a power supply which is in a power supply voltage range (Vdd1 to Vdd3) of the positive polarity amplifier circuit (15) or to a power supply which is in a power supply voltage range (Vdd2 to Vdd4) of the negative polarity amplifier circuit (16).

Abstract: In its many embodiments, the present invention provides certain iminothiazine dioxide compounds, including compounds Formula (I): and tautomers and stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomeros and said stereoisomers, wherein the middle ring (referred to herein as “ring B”) of the tricyclic substituent is an optionally substituted 5-membered ring, and each of the remaining variables shown in the formula are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including Alzheimer's disease, are also disclosed.

Abstract: A display device (1) includes: a scan line drive circuit (4) which line-sequentially selects from among a plurality of scan signal lines; at least one signal line drive circuit (3) which has a receiving circuit that receives a data signal, and which sequentially supplies the data signal to pixels linked to a scan signal line (6) selected by the scan line drive circuit (4); a timing controller (10) which defines, in accordance with sync signals received from an outside source, a non-scan period during which none of the scan signal lines is selected, and which transmits, to the at least one signal line drive circuit (3), an operation discriminant signal that causes the receiving circuit to be underrun during at least part of the non-scan period thus defined. The at least one signal line drive circuit (3) and the timing controller (10) are provided as separate entities.

Abstract: In a backlight (20) including a frame (22) having an opening (22a), and a light guide plate assembly (23) disposed inside the frame (22) and having a light guide plate (24) and a light source (25), the backlight being configured to emit illumination light through the opening (22a), the frame (22) is formed by bending a metal plate and includes a bottom surface portion (22b) facing a rear surface of the light guide plate (24), a peripheral surface portion (22c) standing on a peripheral edge of the bottom surface portion (22b), and an upper surface portion (22d) bent from an upper end of the peripheral surface portion (22c) to form a peripheral edge of the opening, and an outer shape of the light guide plate assembly (23) is smaller than the opening (22a).

Abstract: There are provided a terminal device, a base station device, and an integrated circuit that enable a base station device and a terminal device to determine parameters related to uplink signals or uplink reference signals and to perform efficient communication.

Abstract: A light emitting device includes: a ceramic substrate; a plurality of LED chips; a printed resistor(s) connected in parallel with the plurality of LED chips; a dam resin made of a resin having a low optical transmittance; a fluorescent-material-containing resin layer; and an anode-side electrode and a cathode-side electrode, (a) which are provided on a primary surface of the ceramic substrate so as to face each other along a first direction on the primary surface and (b) which are disposed below at least one of the dam resin and the fluorescent-material-containing resin layer. With the configuration in which a plurality of LEDs, which are connected in a series-parallel connection, are provided on a substrate, it is possible to provide a light emitting device which can achieve restraining of luminance unevenness and an improvement in luminous efficiency.

Abstract: Purified genes encoding cytokines from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.